The overarching goal of the Cancer Prevention and Control (CPC) in Priority Populations postdoctoral research training program is to launch the careers of a new generation of clinical and non-clinical researchers who are prepared to apply a multidisciplinary approach to CPC research targeting priority populations. The program aims to recruit candidates who show promise as future CPC investigators; provide outstanding mentorship; foster a multidisciplinary and transdisciplinary team science environment; and facilitate the attainment of academic career and life skills needed to pursue and sustain long-term success as independent investigators.
We offer a two-year post-doctoral Research Fellowship in Cancer Prevention and Control with a focus on priority populations who are disproportionately vulnerable to develop and/or suffer from cancer. Ideal candidates are physicians who have completed an accredited clinical residency or graduates of PhD or equivalent programs in relevant fields (e.g., clinical psychology, epidemiology, health psychology, anthropology). All fellows will conduct mentored research and will be eligible to earn a Master of Science in Clinical Research (MSCR) through completion of a tailored curriculum integrating biological, medical, psychological, epidemiologic, behavioral, and community perspectives in cancer prevention and control. Stipend and tuition are provided along with an allowance for travel and research expenses. We seek applicants with a commitment to our program's aims who have aspirations for an academic research career.
The CPC Research Training Program includes over 25 faculty researchers and numerous students and research staff. Research foci include cancer prevention and screening, health disparities, comparative effectiveness, behavioral and health psychology, genetics, cancer education, molecular epidemiology, symptom control, palliative care, and more. This fellowship is being offered jointly through the Division of General Internal Medicine and the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.